The Latest Breaking News from CVS Health

The stock market is not making much progress. Buffett stock plunges while Cisco leads the S&P 500.

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

Blue Shield of California will end its CVS Health prescription benefit management contract and tap Amazon to replace it.

CVS's pharmacy benefits division hauled in nearly $27 billion in second quarter revenues, offsetting concerns for a surge in medical cost payouts.

Health insurance CEOs pocket millions while citizens can’t pay the out-of-pocket.

The 2023 Fortune Most Powerful Women in Business list will publish this fall.

Special situation stocks create event-driven opportunities for investors. Here are five that are worth a closer look.

'More seniors are just more comfortable accessing services' they may have delayed during the pandemic, a top UnitedHealth exec says.

The two big drugstore stocks are setting up as potential short-sells. But longs can make a case in certain scenarios, too.

CVS CEO Karen Lynch holds immense power as the leader of one of the biggest health care companies. What is she doing with it?

The drug store industry is well positioned for long-term growth thanks to the growing demand for prescription drugs. Let’s compare CVS Health (CVS) and MedAvail (MDVL) in this space to determine which is better positioned to capitalize on the industry’s solid growth prospects….